Immunogenicity and Safety of Meningococcal Groups A and C and Haemophilus b Conjugate Vaccine in Infants 2 to 5 Months of Age

NCT02919293 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

360

Enrollment

INDUSTRY

Sponsor class

Conditions

Meningitis
Meningococcal Meningitis
Meningococcal Infections

Interventions

BIOLOGICAL: Meningococcal Groups A and C and Haemophilus b Conjugate Vaccine (adjuvant-free)
BIOLOGICAL: Meningococcal Groups A and C and Haemophilus b Conjugate Vaccine(adjuvant)

Sponsor

Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]